CA2185539A1 - Cellules mesenchymateuses a diffusion hematogene - Google Patents

Cellules mesenchymateuses a diffusion hematogene

Info

Publication number
CA2185539A1
CA2185539A1 CA 2185539 CA2185539A CA2185539A1 CA 2185539 A1 CA2185539 A1 CA 2185539A1 CA 2185539 CA2185539 CA 2185539 CA 2185539 A CA2185539 A CA 2185539A CA 2185539 A1 CA2185539 A1 CA 2185539A1
Authority
CA
Canada
Prior art keywords
cells
blood
borne
mammalian blood
fibroblasts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2185539
Other languages
English (en)
Inventor
Anthony Cerami
Richard J. Bucala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Picower Institute for Medical Research
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2185539 priority Critical patent/CA2185539A1/fr
Publication of CA2185539A1 publication Critical patent/CA2185539A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/13—Coculture with; Conditioned medium produced by connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
    • C12N2502/1323—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)

Abstract

La présente invention se rapporte à une population de cellules mammaliennes à diffusion hématogène qui expriment un profil unique de marqueurs de surface, dont certains marqueurs typiques des fibroblastes du tissu conjonctif, et sont appelées ici "cellules mésenchymateuses à diffusion hématogène". Cette invention se rapporte notamment à l'isolation, la caractérisation et les utilisations de ces cellules mésenchymateuses à diffusion hématogène. Les cellules de la présente invention peuvent se distinguer des leucocytes du sang périphérique par leur taille distincte, leur morphologie, le phénotype de surface cellulaire et les activités biologiques, et peuvent se distinguer en outre des fibroblastes du tissu conjonctif par d'autres marqueurs phénotypiques de surface. Ces cellules prolifèrent en culture, et in vivo, tel que mis en évidence dans des modèles animaux, et peuvent migrer dans des sites lésionnels à partir du sang. Ces cellules mésenchymateuses à diffusion hématogène peuvent avoir par conséquent une large plage d'applications, notamment, mais non exclusivement, l'activation de la cicatrisation, le remodelage tissulaire et en thérapie génique.
CA 2185539 1994-03-16 1994-03-16 Cellules mesenchymateuses a diffusion hematogene Abandoned CA2185539A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2185539 CA2185539A1 (fr) 1994-03-16 1994-03-16 Cellules mesenchymateuses a diffusion hematogene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2185539 CA2185539A1 (fr) 1994-03-16 1994-03-16 Cellules mesenchymateuses a diffusion hematogene

Publications (1)

Publication Number Publication Date
CA2185539A1 true CA2185539A1 (fr) 1995-09-21

Family

ID=4158910

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2185539 Abandoned CA2185539A1 (fr) 1994-03-16 1994-03-16 Cellules mesenchymateuses a diffusion hematogene

Country Status (1)

Country Link
CA (1) CA2185539A1 (fr)

Similar Documents

Publication Publication Date Title
US5654186A (en) Blood-borne mesenchymal cells
US5804446A (en) Blood-borne mesenchymal cells
US6054121A (en) Modulation of immune responses in blood-borne mesenchymal cells
Castro-Malaspina et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny
JP4767983B2 (ja) 骨髄に由来するＴＧＦβ１応答細胞
JP4526186B2 (ja) 造血幹細胞を試験管内で維持する方法と組成物
EP1876233A1 (fr) Cellules capables de differenciation en cellules de muscle cardiaque
CN110914410A (zh) γδT细胞扩增、组合物及其使用方法
WO1997032992A1 (fr) Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages
JPWO2003087349A1 (ja) 間葉系細胞から膵β細胞を形成する方法
JP2008125540A (ja) 人工皮膚
AU693441B2 (en) Blood-borne mesenchymal cells
CA2185539A1 (fr) Cellules mesenchymateuses a diffusion hematogene
NZ265435A (en) Blood-borne mesenchymal cells (fibroblasts) for wound healing and tissue remodelling
US20030003576A1 (en) Peripheral blood fibrocytes differentiation pathway and migration to wound sites
US20200299641A1 (en) Thymic Epithelial Cells, Exosomes Derived Therefrom, and Methods of Making and Using Same
RU2784566C2 (ru) РАЗМНОЖЕНИЕ И ПРИМЕНЕНИЕ НЕГЕМОПОЭТИЧЕСКИХ ТКАНЕРЕЗИДЕНТНЫХ γδ Т-КЛЕТОК
US20040214323A1 (en) Long lived keratinocytes
AU2005200383B2 (en) TGFbeta1-responsive cells from bone marrow
CN116987199A (zh) 表达靶向fap的嵌合抗原受体巨噬细胞及其构建方法和应用
Jakic-Razumovic et al. CD8+ activated T lymphocytes produce an in vitro skin graft-versus-host reaction in an organotypic skin culture model
JPS61251624A (ja) 骨髄細胞刺激因子

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued